Trandolapril
Trandolapril is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
0
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Metabolic Effects of Antihypertensive Drugs on People With Metabolic Syndrome (The MEAD Study)
Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone
Bioequivalence Study of Trandolapril 4 mg Tablets of Dr. Reddy's Under Fasting Conditions
Bioequivalence Study of Trandolapril 4 mg Tablets of Dr. Reddy's Under Fed Conditions
Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAIL)
Clinical Trials (6)
Metabolic Effects of Antihypertensive Drugs on People With Metabolic Syndrome (The MEAD Study)
Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone
Bioequivalence Study of Trandolapril 4 mg Tablets of Dr. Reddy's Under Fasting Conditions
Bioequivalence Study of Trandolapril 4 mg Tablets of Dr. Reddy's Under Fed Conditions
Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAIL)
A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT)
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6